NCT00808535

Brief Summary

The goal of this research study is to demonstrate that Cardiac Perfusion MRI with Vasomotor Stress may serve as a non-invasive and less risky imaging technique for detecting non-obstructive perfusion deficits and/or abnormalities in myocardial blood flow (MBF) in patients with endothelial dysfunction. This is a controlled study, which will enroll approximately 60 subjects (30 diabetics and 30 non-diabetics to serve as healthy controls), and will include male and non-pregnant females, between the ages 18-50 years. All eligible participants will sign an informed consent and will complete a Lifestyle Questionnaire. They will undergo blood work which includes:

  • 2-hour Oral Glucose Tolerance Test and Fasting Labs for Glucose, Insulin, C-Peptide, HbA1c, Creatinine, and Lipid Panel.
  • Urine Albumin to Creatinine ratio for microalbuminuria.
  • Serum inflammatory markers: E-selectin, homocysteine, ADMA, VCAM, IL-6, TNFalpha, hs-CRP and PAI-1. After blood work, all participants will undergo cardiac MR perfusion imaging procedure with Cold Pressor Test and Adenosine Stress Test.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2009

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

February 9, 2009

Status Verified

February 1, 2009

Enrollment Period

1 year

First QC Date

December 15, 2008

Last Update Submit

February 6, 2009

Conditions

Keywords

Endothelial dysfunctionCardiac Perfusion MRIVasomotor StressCold Pressor TestAdenosine Stress

Study Arms (2)

diabetics

Procedure: Cardiac Perfusion MRI w Vasomotor Stress

healthy controls

Procedure: Cardiac Perfusion MRI w Vasomotor Stress

Interventions

All participants will undergo Cardiac Perfusion MRI with Vasomotor Stress. Vasomotor Stress will include both Cold Pressor Test and Adenosine Stress Test.

diabeticshealthy controls

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Diagnosed diabetics (less than 5 years) without documented coronary artery disease recruited from UCLA Ambulatory clinics. Healthy controls from general population.

You may qualify if:

  • Age 18 to 50 years
  • Should be able to sign an informed consent and HIPAA Agreement
  • healthy, non-diabetic individuals
  • diabetic individuals without documented coronary artery disease
  • Diagnosed diabetics less than 5 years
  • HbA1c less than 8.0

You may not qualify if:

  • Children under 18 years and adults above 50 years
  • Type 1 DM
  • Lactating and Pregnant females
  • BMI less than 35
  • Contraindication to MRI such as pacemaker, defibrillator implants, etc.
  • Allergy to MR (paramagnetic) contrast
  • History of Angina, MI, or documented Coronary Artery Disease
  • Previous history of CHF, CABG, Angioplasty and Stenting
  • History of Valvular Heart Disease and Congenital Heart Disease
  • History of Peripheral Vascular Disease
  • History of Cardiac Arrythmias and anti-coagulation therapy
  • History of Cerebro-vascular accidents or TIA
  • History of active diabetic retinopathy and nephropathy
  • Uncontrolled hypertension (systolic \> 170 and diastolic \>100 mm Hg
  • End Stage Renal Disease and patients on dialysis
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Radiological Sciences

Los Angeles, California, 91324, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Stefan Ruehm, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 15, 2008

First Posted

December 16, 2008

Study Start

February 1, 2009

Primary Completion

February 1, 2010

Study Completion

March 1, 2010

Last Updated

February 9, 2009

Record last verified: 2009-02

Locations